Annual Operating Profit
$26.79 M
+$57.35 M+187.63%
December 31, 2023
Summary
- As of February 8, 2025, SPRO annual operating income is $26.79 million, with the most recent change of +$57.35 million (+187.63%) on December 31, 2023.
- During the last 3 years, SPRO annual operating profit has risen by +$105.90 million (+133.86%).
- SPRO annual operating profit is now at all-time high.
Performance
SPRO Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$18.59 M
+$468.00 K+2.46%
September 30, 2024
Summary
- As of February 8, 2025, SPRO quarterly operating income is -$18.59 million, with the most recent change of +$468.00 thousand (+2.46%) on September 30, 2024.
- Over the past year, SPRO quarterly operating profit has dropped by -$69.13 million (-136.79%).
- SPRO quarterly operating profit is now -136.79% below its all-time high of $50.53 million, reached on December 31, 2023.
Performance
SPRO Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$1.10 M
-$21.96 M-105.29%
September 30, 2024
Summary
- As of February 8, 2025, SPRO TTM operating income is -$1.10 million, with the most recent change of -$21.96 million (-105.29%) on September 30, 2024.
- Over the past year, SPRO TTM operating profit has dropped by -$27.89 million (-104.12%).
- SPRO TTM operating profit is now -104.08% below its all-time high of $27.03 million, reached on March 31, 2024.
Performance
SPRO TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
SPRO Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +187.6% | -136.8% | -104.1% |
| 3 y3 years | +133.9% | -136.8% | -104.1% |
| 5 y5 years | +162.6% | -136.8% | -104.1% |
SPRO Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +130.4% | -136.8% | +38.5% | -104.1% | +98.9% |
| 5 y | 5-year | at high | +130.4% | -136.8% | +38.5% | -104.1% | +98.9% |
| alltime | all time | at high | +130.4% | -136.8% | +38.5% | -104.1% | +98.9% |
Spero Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$18.59 M(-2.5%) | -$1.10 M(-105.3%) |
| Jun 2024 | - | -$19.06 M(+36.3%) | $20.86 M(-22.8%) |
| Mar 2024 | - | -$13.98 M(-127.7%) | $27.03 M(+0.9%) |
| Dec 2023 | $26.79 M(-187.6%) | $50.53 M(+1398.6%) | $26.79 M(+1168.3%) |
| Sep 2023 | - | $3.37 M(-126.2%) | $2.11 M(-115.9%) |
| Jun 2023 | - | -$12.89 M(-9.4%) | -$13.25 M(-9.2%) |
| Mar 2023 | - | -$14.23 M(-155.0%) | -$14.59 M(-52.3%) |
| Dec 2022 | -$30.57 M(-65.3%) | $25.86 M(-315.7%) | -$30.57 M(-63.6%) |
| Sep 2022 | - | -$11.99 M(-15.8%) | -$83.93 M(-11.2%) |
| Jun 2022 | - | -$14.23 M(-52.9%) | -$94.46 M(-4.4%) |
| Mar 2022 | - | -$30.21 M(+9.8%) | -$98.78 M(+12.3%) |
| Dec 2021 | -$87.97 M(+11.2%) | -$27.50 M(+22.1%) | -$87.97 M(+11.0%) |
| Sep 2021 | - | -$22.52 M(+21.5%) | -$79.27 M(+4.6%) |
| Jun 2021 | - | -$18.54 M(-4.4%) | -$75.76 M(+0.1%) |
| Mar 2021 | - | -$19.40 M(+3.2%) | -$75.69 M(-4.3%) |
| Dec 2020 | -$79.11 M | -$18.80 M(-1.2%) | -$79.11 M(-8.2%) |
| Sep 2020 | - | -$19.02 M(+2.9%) | -$86.20 M(+1.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2020 | - | -$18.48 M(-19.0%) | -$85.17 M(+6.0%) |
| Mar 2020 | - | -$22.82 M(-11.8%) | -$80.34 M(+27.1%) |
| Dec 2019 | -$63.22 M(+47.7%) | -$25.88 M(+43.9%) | -$63.22 M(+30.6%) |
| Sep 2019 | - | -$17.98 M(+31.7%) | -$48.42 M(+17.0%) |
| Jun 2019 | - | -$13.65 M(+139.7%) | -$41.37 M(+9.8%) |
| Mar 2019 | - | -$5.70 M(-48.6%) | -$37.69 M(-12.0%) |
| Dec 2018 | -$42.81 M(+2.6%) | -$11.08 M(+1.4%) | -$42.81 M(-6.4%) |
| Sep 2018 | - | -$10.94 M(+9.7%) | -$45.72 M(+2.2%) |
| Jun 2018 | - | -$9.97 M(-7.8%) | -$44.75 M(-0.4%) |
| Mar 2018 | - | -$10.82 M(-22.7%) | -$44.95 M(+7.7%) |
| Dec 2017 | -$41.73 M(+25.6%) | -$14.00 M(+40.5%) | -$41.73 M(+14.2%) |
| Sep 2017 | - | -$9.97 M(-2.0%) | -$36.54 M(+5.9%) |
| Jun 2017 | - | -$10.16 M(+33.8%) | -$34.49 M(+41.8%) |
| Mar 2017 | - | -$7.60 M(-13.7%) | -$24.32 M(+45.4%) |
| Dec 2016 | -$33.22 M(+149.3%) | -$8.81 M(+11.3%) | -$16.72 M(+111.3%) |
| Sep 2016 | - | -$7.91 M | -$7.91 M |
| Dec 2015 | -$13.33 M | - | - |
FAQ
- What is Spero Therapeutics annual operating income?
- What is the all time high annual operating profit for Spero Therapeutics?
- What is Spero Therapeutics annual operating profit year-on-year change?
- What is Spero Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Spero Therapeutics?
- What is Spero Therapeutics quarterly operating profit year-on-year change?
- What is Spero Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Spero Therapeutics?
- What is Spero Therapeutics TTM operating profit year-on-year change?
What is Spero Therapeutics annual operating income?
The current annual operating profit of SPRO is $26.79 M
What is the all time high annual operating profit for Spero Therapeutics?
Spero Therapeutics all-time high annual operating income is $26.79 M
What is Spero Therapeutics annual operating profit year-on-year change?
Over the past year, SPRO annual operating income has changed by +$57.35 M (+187.63%)
What is Spero Therapeutics quarterly operating income?
The current quarterly operating profit of SPRO is -$18.59 M
What is the all time high quarterly operating profit for Spero Therapeutics?
Spero Therapeutics all-time high quarterly operating income is $50.53 M
What is Spero Therapeutics quarterly operating profit year-on-year change?
Over the past year, SPRO quarterly operating income has changed by -$69.13 M (-136.79%)
What is Spero Therapeutics TTM operating income?
The current TTM operating profit of SPRO is -$1.10 M
What is the all time high TTM operating profit for Spero Therapeutics?
Spero Therapeutics all-time high TTM operating income is $27.03 M
What is Spero Therapeutics TTM operating profit year-on-year change?
Over the past year, SPRO TTM operating income has changed by -$27.89 M (-104.12%)